Michel Lagarde - 01 May 2025 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
Director
Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
01 May 2025
Net transactions value
$0
Form type
4
Filing time
05 May 2025, 16:20:54 UTC
Previous filing
04 Mar 2025
Next filing
02 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lagarde Michel Director C/O VERTEX PHARMACEUTICALS INCORPORATED, 50 NORTHERN AVE, BOSTON /s/ Christiana Stevenson, Attorney-in-Fact 05 May 2025 0001518973

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRTX Stock Option (Right to Buy) Award $0 +2,398 $0.000000 2,398 01 May 2025 Common Stock 2,398 $502.97 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested.